4501 - 4510 of 8620 Results
Title
Year
-
OPENTitle: Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc AnalysesJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 2Start Page: 711End Page: 723Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00332-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00332-0.pdfCitation Count: 1
-
RESTRICTEDTitle: The path linking excessive daytime sleepiness and activity of daily living in Parkinson’s disease: the longitudinal mediation effect of autonomic dysfunctionJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4777End Page: 4784Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-022-06081-0Citation Count: 6
-
OPENTitle: Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 CountriesJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 303End Page: 318Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00313-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00313-9.pdfCitation Count: 11
-
OPENTitle: Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label TreatmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 459End Page: 469Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00317-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00317-5.pdfCitation Count: 5
-
OPENTitle: Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome AssessmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1319End Page: 1340Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00375-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00375-3.pdfCitation Count: 23
-
OPENTitle: Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON TrialJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1409End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00371-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00371-7.pdfCitation Count: 7
-
OPENTitle: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein ToxicityJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 1018End Page: 1036Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-022-01199-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-022-01199-7.pdfCitation Count: 14
-
OPENTitle: The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in EnglandJournal Name: PharmacoEconomicsPublisher: Springer Science and Business Media LLCVol: 40Issue #: 5Start Page: 559End Page: 574Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40273-022-01132-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40273-022-01132-y.pdfCitation Count: 10
-
OPENTitle: An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocolJournal Name: Pilot and Feasibility StudiesPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40814-022-00988-3Best OA location URL: https://pilotfeasibilitystudies.biomedcentral.com/track/pdf/10.1186/s40814-022-00988-3Citation Count: 11
-
OPENTitle: Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stressJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-20261-0Best OA location URL: https://www.nature.com/articles/s41598-022-20261-0.pdfCitation Count: 20